A META-ANALYSIS OF LOW MOLECULAR WEIGHT HEPARIN VERSUS VITAMIN K ANTAGONIST FOR THE PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER

Jaglal Michael; Visweshwar Nathan; Djulbegovic Benjamin

首页> 外文期刊>American Journal of Hematology >A META-ANALYSIS OF LOW MOLECULAR WEIGHT HEPARIN VERSUS VITAMIN K ANTAGONIST FOR THE PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER

【24h】

A META-ANALYSIS OF LOW MOLECULAR WEIGHT HEPARIN VERSUS VITAMIN K ANTAGONIST FOR THE PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER

机译：低分子肝素对维生素K拮抗剂的meta分析，用于预防癌症患者的复发性静脉血栓形成

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《American Journal of Hematology》 |2016年第9期|共1页
作者
Jaglal Michael; Visweshwar Nathan; Djulbegovic Benjamin;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. A META-ANALYSIS OF LOW MOLECULAR WEIGHT HEPARIN VERSUS VITAMIN K ANTAGONIST FOR THE PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER [J] . Jaglal Michael, Visweshwar Nathan, Djulbegovic Benjamin American Journal of Hematology . 2016,第9期

机译：低分子肝素对维生素K拮抗剂的meta分析，用于预防癌症患者的复发性静脉血栓形成
2. Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study [J] . Woodruff Seth, Lee Agnes Y. Y., Carrier Marc, Journal of thrombosis and thrombolysis . 2019,第4期

机译：低分子量 - 肝素与香豆素用于预防高危活性癌症患者的复发静脉血栓栓塞：凝块研究的后HOC分析
3. Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight-heparin for the prevention of venous thromboembolism in patients with cancer: A meta-analysis study [J] . Brunetti Natale Daniele, Gesuete Enrico, De Gennaro Luisa, International Journal of Cardiology . 2017,第期

机译：直接口服抗凝血剂与维生素-K抑制剂和低分子量 - 肝素用于预防癌症患者的静脉血栓栓塞：荟萃分析研究
4. Coronary Syndrome and Low Molecular Weight Heparin, Glycoprotein Ilb/IHa Receptor Antagonists, Clopidogrel, Urgent Revascularization: Selective Use or Polytherapy for All Patients [C] . International Congress on Coronary Artery Disease . 2003

机译：冠状动脉综合征和低分子量肝素，糖蛋白ILB / IHA受体拮抗剂，氯吡格雷，紧急血运重建：所有患者的选择性使用或聚餐
5. Evaluating risk of recurrent venous thromboembolism during the anticoagulation period in patients with malignancy [D] . Louzada, Martha de Lacerda. 2011

机译：评估恶性肿瘤患者抗凝治疗期间静脉血栓栓塞复发的风险
6. Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study [O] . Seth Woodruff, Agnes Y. Y. Lee, Marc Carrier, -1

机译：低分子量肝素与香豆素在高风险和低风险活动性癌症患者中预防复发性静脉血栓栓塞的发生：CLOT研究的事后分析
7. Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences [O] . 2017

机译：阿哌沙班与低分子量肝素/维生素K拮抗剂相比治疗静脉血栓栓塞和预防复发的成本效益

A META-ANALYSIS OF LOW MOLECULAR WEIGHT HEPARIN VERSUS VITAMIN K ANTAGONIST FOR THE PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER

著录项

相似文献

相关主题

期刊订阅